Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research.
Journal
Carcinogenesis
ISSN: 1460-2180
Titre abrégé: Carcinogenesis
Pays: England
ID NLM: 8008055
Informations de publication
Date de publication:
21 06 2021
21 06 2021
Historique:
received:
18
02
2021
revised:
14
05
2021
accepted:
24
05
2021
pubmed:
27
5
2021
medline:
23
11
2021
entrez:
26
5
2021
Statut:
ppublish
Résumé
Recently, ovarian cancer research has evolved considerably because of the emerging recognition that rather than a single disease, ovarian carcinomas comprise several different histotypes that vary by etiologic origin, risk factors, molecular profiles, therapeutic approaches and clinical outcome. Despite significant progress in our understanding of the etiologic heterogeneity of ovarian cancer, as well as important clinical advances, it remains the eighth most frequently diagnosed cancer in women worldwide and the most fatal gynecologic cancer. The International Agency for Research on Cancer and the United States National Cancer Institute jointly convened an expert panel on ovarian carcinoma to develop consensus research priorities based on evolving scientific discoveries. Expertise ranged from etiology, prevention, early detection, pathology, model systems, molecular characterization and treatment/clinical management. This report summarizes the current state of knowledge and highlights expert consensus on future directions to continue advancing etiologic, epidemiologic and prognostic research on ovarian carcinoma.
Identifiants
pubmed: 34037709
pii: 6284121
doi: 10.1093/carcin/bgab043
pmc: PMC8427725
doi:
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
785-793Subventions
Organisme : Medical Research Council
ID : MC_UU_00004/01
Pays : United Kingdom
Informations de copyright
Published by Oxford University Press 2021.
Références
Lancet. 2017 Oct 28;390(10106):1949-1961
pubmed: 28916367
Clin Cancer Res. 2020 Oct 15;26(20):5400-5410
pubmed: 32737030
Histopathology. 2016 Aug;69(2):288-97
pubmed: 26799366
J Clin Oncol. 2009 Mar 20;27(9):1419-25
pubmed: 19224846
Clin Cancer Res. 2019 Oct 1;25(19):5937-5946
pubmed: 31142506
Ann Oncol. 2020 Sep;31(9):1240-1250
pubmed: 32473302
Ann Oncol. 2013 Nov;24 Suppl 8:viii28-viii35
pubmed: 24131966
Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3921-6
pubmed: 22331912
Obstet Gynecol. 2018 Sep;132(3):545-554
pubmed: 30095787
Nat Genet. 2017 May;49(5):680-691
pubmed: 28346442
Cancer Causes Control. 2017 May;28(5):487-495
pubmed: 28283879
J Natl Cancer Inst. 2019 Feb 1;111(2):137-145
pubmed: 29860330
Int J Gynecol Cancer. 2016 Jun;26(5):892-7
pubmed: 27051053
Genome Med. 2018 Oct 31;10(1):81
pubmed: 30382883
JAMA. 2018 Feb 13;319(6):588-594
pubmed: 29450531
N Engl J Med. 2003 Jan 16;348(3):203-13
pubmed: 12529460
Gynecol Oncol. 2006 Jan;100(1):58-64
pubmed: 16137750
J Natl Cancer Inst. 2014 Feb;106(2):djt431
pubmed: 24503200
Cell Rep. 2020 Jan 14;30(2):525-540.e7
pubmed: 31940494
Int J Gynecol Cancer. 2012 May;22 Suppl 1:S29-34
pubmed: 22543918
Cell Rep. 2020 Apr 14;31(2):107502
pubmed: 32294438
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
Front Oncol. 2016 Jan 14;5:308
pubmed: 26835417
Clin Cancer Res. 2018 Feb 1;24(3):569-580
pubmed: 29061645
Nature. 2015 May 28;521(7553):489-94
pubmed: 26017449
N Engl J Med. 2019 Nov 14;381(20):1929-1939
pubmed: 31722153
J Clin Oncol. 2014 May 20;32(15):1547-53
pubmed: 24567435
N Engl J Med. 2016 Dec;375(22):2154-2164
pubmed: 27717299
PLoS One. 2013 Sep 04;8(9):e72162
pubmed: 24023729
J Pathol. 2017 Sep;243(1):16-25
pubmed: 28608929
N Engl J Med. 2017 May 11;376(19):1835-1848
pubmed: 28489996
J Natl Cancer Inst. 2019 Feb 1;111(2):129-136
pubmed: 29790947
Nat Rev Cancer. 2015 Nov;15(11):668-79
pubmed: 26493647
Clin Cancer Res. 2017 Oct 1;23(19):5912-5922
pubmed: 28637689
Am J Surg Pathol. 2006 Feb;30(2):230-6
pubmed: 16434898
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Nat Rev Dis Primers. 2016 Aug 25;2:16061
pubmed: 27558151
Gynecol Oncol. 2017 Apr;145(1):27-31
pubmed: 28209497
F1000Res. 2018 Mar 15;7:326
pubmed: 29560266
Hum Pathol. 2011 Jul;42(7):918-31
pubmed: 21683865
J Gynecol Oncol. 2020 Sep;31(5):e86
pubmed: 32808504
Gynecol Oncol. 2010 Sep;118(3):262-7
pubmed: 20573392
Int J Gynecol Cancer. 2019 Oct;29(8):1327-1331
pubmed: 31420412
Am J Surg Pathol. 2010 Oct;34(10):1407-16
pubmed: 20861711
Cancer Res. 2020 Feb 15;80(4):877-889
pubmed: 31806642
J Clin Oncol. 2020 Jun 1;38(16):1814-1823
pubmed: 32275468
Cancer Res. 2019 Oct 15;79(20):5442-5451
pubmed: 31462430
Nat Genet. 2018 Sep;50(9):1262-1270
pubmed: 30104763
Gynecol Oncol. 2013 Jan;128(1):6-11
pubmed: 23006973
N Engl J Med. 2011 Dec 29;365(26):2473-83
pubmed: 22204724
Nat Med. 2019 May;25(5):838-849
pubmed: 31011202
Gynecol Oncol. 2019 Feb;152(2):426-433
pubmed: 30503267
J Natl Cancer Inst. 2019 Jan 1;111(1):60-68
pubmed: 29718305
Curr Oncol. 2015 Aug;22(4):e282-93
pubmed: 26300679
Sci Transl Med. 2018 Mar 21;10(433):
pubmed: 29563323
Nat Rev Cancer. 2011 Sep 23;11(10):719-25
pubmed: 21941283
Nat Commun. 2013;4:2126
pubmed: 23839242
Nat Commun. 2019 Nov 26;10(1):5367
pubmed: 31772167
J Clin Oncol. 2016 Aug 20;34(24):2888-98
pubmed: 27325851
Cancer Discov. 2017 Sep;7(9):984-998
pubmed: 28588062
Transl Res. 2019 Mar;205:77-91
pubmed: 30391474
J Pathol Clin Res. 2018 Oct;4(4):250-261
pubmed: 30062862
Am J Pathol. 2016 Apr;186(4):733-47
pubmed: 27012190
Int J Gynecol Pathol. 2016 Sep;35(5):430-41
pubmed: 26974996
J Ovarian Res. 2019 Nov 8;12(1):105
pubmed: 31703723
J Natl Cancer Inst. 2008 Oct 15;100(20):1432-8
pubmed: 18840817
Br J Cancer. 2019 Apr;120(8):855-860
pubmed: 30894687
Obstet Gynecol. 2020 Feb;135(2):328-339
pubmed: 31923082
Cancer Cell. 2013 Dec 9;24(6):751-65
pubmed: 24332043
PLoS Med. 2008 Dec 2;5(12):e232
pubmed: 19053170
Am J Surg Pathol. 2001 Oct;25(10):1283-9
pubmed: 11688463
Nat Commun. 2015 Jun 17;6:7419
pubmed: 26080861
Int J Gynecol Cancer. 2017 Mar;27(3):437-443
pubmed: 28072594
Gynecol Oncol. 2009 Feb;112(2):422-36
pubmed: 18990435
J Clin Oncol. 2007 Sep 1;25(25):3985-90
pubmed: 17761984
Clin Cancer Res. 2014 Mar 1;20(5):1288-97
pubmed: 24398046
Nat Commun. 2019 Sep 2;10(1):3935
pubmed: 31477716
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Clin Cancer Res. 2020 Oct 15;26(20):5411-5423
pubmed: 32554541
Gynecol Oncol. 2018 Feb;148(2):275-280
pubmed: 29195926
J Natl Cancer Inst. 2017 Oct 1;109(10):
pubmed: 29117355
Int J Cancer. 2017 Jun 1;140(11):2451-2460
pubmed: 28257597
Int J Gynecol Cancer. 2011 Jul;21(5):846-51
pubmed: 21670699
Ann Oncol. 2019 Feb 1;30(2):303-309
pubmed: 30576422
Clin Cancer Res. 2008 Aug 15;14(16):5198-208
pubmed: 18698038
JNCI Cancer Spectr. 2018 Dec 14;2(4):pky061
pubmed: 31360879
J Natl Cancer Inst. 2018 Jul 1;110(7):750-757
pubmed: 29281053
Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1509-1517
pubmed: 30377203
Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47
pubmed: 22144499
Lancet Oncol. 2012 Apr;13(4):385-94
pubmed: 22361336
Best Pract Res Clin Obstet Gynaecol. 2020 May;65:32-45
pubmed: 32273169
Gynecol Oncol. 2007 Jun;105(3):801-12
pubmed: 17433422
J Clin Invest. 2013 Jan;123(1):517-25
pubmed: 23257362
Int J Cancer. 2020 Feb 1;146(3):749-758
pubmed: 30968402
Am J Obstet Gynecol. 2020 Jan;222(1):56.e1-56.e17
pubmed: 31351062
J Ovarian Res. 2020 Oct 19;13(1):124
pubmed: 33076944
J Natl Cancer Inst. 2017 Jul 1;109(7):
pubmed: 28376175